Dognosis
Tracked across 2 events · 28 articles · First seen Aug 14, 2026 · Last active Sep 12, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
Impact: Dognosis is the central entity, developing and testing the canine-AI cancer screening technology. Its Phase 3 trial and planned product launch could position it as a leader in low-cost cancer prescreening, with potential for significant growth.
Aug 14, 2026 · 8 articles
Tech
Bengaluru-based startup Dognosis is combining trained sniffer dogs with artificial intelligence to develop a non-invasive cancer screening test based on human breath samples. Dogs such as Chloe, a Labrador mix, wear 3D-printed helmets and harnesses…
Impact: Central actor developing the AI-assisted canine cancer screening technology and reporting over 90 percent accuracy in its study. Commercial launch targeted for 2027, but independent validation is still pending.
Sep 07, 2026 · 20 articles
70
Dognosis plans commercial launchDognosis AI Dog Cancer...
60
Dognosis collaborating with hospitalsDognosis AI Dog Cancer...
55
Dognosis trained dogsDognosis AI Dog Cancer...
40
Accel-KKR backed startup DognosisDognosis AI Dog Cancer...
30
Santhosh Kumar Devadas voiced cautious optimism DognosisDognosis AI Dog Cancer...
25
Neelesh Reddy questioned technology usefulness DognosisDognosis AI Dog Cancer...
ERGEN INTELLIGENCE
Track Dognosis live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard